- NCT00025896
Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease
Phase 2Completed - NCT00025935
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
Recruiting - NCT00027222
The Early Treatment for Retinopathy of Prematurity Study (ETROP)
Phase 2Unknown - NCT00025857
Brain Function in Mentally Ill Adolescents
Completed - NCT00025818
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
Phase 3Completed - NCT00025870
Studies of Children With Metabolic and Other Genetic Disorders
Completed - NCT00025883
Leptin to Treat Lipodystrophy
Phase 2Completed - NCT00025844
Fear Conditioning Using Computer-Generated Virtual Reality
Completed - NCT00025831
Biological Specimen Collection for Laboratory Methods Development and Training Purposes
Completed - NCT00025805
G-CSF to Treat Crohn's Disease
Phase 1Completed - NCT00025792
Clinical Trial of Pramipexole in Bipolar Depression
Phase 2Completed - NCT00025779
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
Not ApplicableCompleted - NCT00025766
Angioplasty and Heart Stents to Treat Individuals With an Occluded Artery Following a Heart Attack
Phase 4Completed - NCT00025753
Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution
Not ApplicableCompleted - NCT00025740
Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
Phase 4Completed - NCT00025727
Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Phase 3Unknown - NCT00025701
EEG and EMG Studies of Hand Dystonia
Completed - NCT00025714
Study of Specimens Obtained During Epilepsy Surgery
Completed - NCT00024986
Tenofovir Disoproxil Fumarate to Treat Pediatric HIV
Phase 1Completed - NCT00024999
EEG and EMG Analysis of Ideomotor Apraxia
Completed - NCT00024960
Dopamine Function in Developmental Stuttering
Completed - NCT00024921
The Genetics of Kidneys in Diabetes (GoKinD) Study
Completed - NCT00024934
B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency
Phase 1Completed - NCT00024908
Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex
Completed - NCT00024804
A Natural History Study of Bone and Mineral Disorders
Recruiting - NCT00024843
Family Based Interventions: Preschool Children and Parent
Completed - NCT00024791
Eye-Hand Coordination in Children With Spastic Diplegia
Completed - NCT00024817
Energy Expenditure, Diet and Body Fat in Children
Completed - NCT00024830
Peer-Based Skills Training to Enhance Teen Weight Loss
Completed - NCT00024687
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
Phase 1Withdrawn - NCT00024648
Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies
Phase 1Completed - NCT00024661
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
Phase 1Completed - NCT00024674
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
Phase 1Withdrawn - NCT00024622
PET Scanning in Parkinson s Disease
Completed - NCT00024596
Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)
Completed - NCT00024583
Prenatal Nutrition and Adult Disease
Completed - NCT00024570
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
Phase 1Completed - NCT00024557
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Phase 1Completed - NCT00024531
Lipitor as a Treatment for Alzheimer's Disease
Phase 2Completed - NCT00024544
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
Phase 2Completed - NCT00024518
Interferon-Alpha for Diabetes Mellitus Type 1
Phase 2Completed - NCT00024505
Multidisciplinary Study of Right Ventricular Dysplasia
Completed - NCT00024492
Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer
Phase 1Completed - NCT00024479
Studies of the Natural History of Rheumatic Diseases
Recruiting - NCT00023582
HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru
Completed - NCT00023595
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
Phase 3Completed - NCT00023439
TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment
Completed - NCT00023348
TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB
Phase 2Completed - NCT00023504
Antibody Production in Immune Disorders
Phase 4Terminated - NCT00023361
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
Not ApplicableCompleted - NCT00023374
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
Not ApplicableCompleted - NCT00023387
TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine
Not ApplicableCompleted - NCT00023400
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
Phase 4Completed - NCT00023426
TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis
Phase 2Completed - NCT00023569
Electrical Stimulation to Improve Hand Function in Patients With Chronic Stroke
Completed - NCT00023335
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
Phase 3Completed - NCT00023452
Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
Phase 3Completed - NCT00023413
TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz
Phase 2Completed - NCT00023465
Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging
Unknown - NCT00023530
Blood and Marrow Transplant Clinical Research Network
Not ApplicableCompleted - NCT00023556
Genetic Architecture of Heart Disease in Rural Brazil
Completed - NCT00023491
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
Completed - NCT00023543
Reduction of Triglycerides in Women on Hormone Replacement Therapy
Phase 2Completed - NCT00023322
Pegylated Interferon to Treat Chronic Hepatitis D
Phase 2Completed - NCT00023309
Lamivudine and Adefovir to Treat Chronic Hepatitis B
Phase 2Completed - NCT00023296
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension
Phase 1Completed - NCT00011011
Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Phase 1Completed - NCT00001023
The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients
Not ApplicableCompleted - NCT00000849
A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children
Phase 1Completed - NCT00002281
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
Not ApplicableCompleted - NCT00000986
The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex
Phase 1Completed - NCT00006643
Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus
Completed - NCT00006630
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
Phase 1Withdrawn - NCT00006617
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Not ApplicableCompleted - NCT00006604
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Phase 1Completed - NCT00006591
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
Not ApplicableUnknown - NCT00006441
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
Not ApplicableCompleted - NCT00006325
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
Phase 1Completed - NCT00015704
Effect of Interleukin-2 on HIV Treatment Interruption
Not ApplicableCompleted - NCT00006509
A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
Phase 1Completed - NCT00002071
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not ApplicableCompleted - NCT00006495
Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
Phase 1Completed - NCT00002107
A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Phase 1Completed - NCT00002073
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not ApplicableCompleted - NCT00006490
A Comparison of Two Tests for Anti-HIV Drug Resistance
Completed - NCT00011037
ALVAC-HIV vCP1452 Alone and Combined With MN rgp120
Phase 2Completed - NCT00011050
Effects of Storage on Lactate in Blood Samples
Completed - NCT00011089
Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations
Not ApplicableUnknown - NCT00000966
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
Phase 1Completed - NCT00011128
Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment
Phase 3Withdrawn - NCT00006291
Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Phase 2Completed - NCT00000626
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Phase 2Completed - NCT00009555
Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat
Phase 4Completed - NCT00002321
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Phase 1Completed - NCT00009061
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
Phase 3Unknown - NCT00008866
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
Phase 2Withdrawn - NCT00008853
Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
Phase 1Completed - NCT00008840
A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
Completed - NCT00011479
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Phase 1Completed - NCT00008554
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
Phase 3Unknown